Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324144811> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4324144811 abstract "Background: Eosinophilic cystitis is a rare inflammatory cystitis of unknown origin. Common symptoms include urinary frequency, urgency, pain, and recurrent urinary tract infections. Currently used treatments include corticosteroids, anti-inflammatory drugs, antihistamines, and antibiotics. Here we present a case of successful treatment of eosinophilic cystitis with mepolizumab. Case Presentation: A 41-year-old female presented with urinary frequency, urgency, and suprapubic pain. She underwent multiple tests including cystoscopy and biopsy, which revealed a diagnosis of eosinophilic cystitis in 2000. She was initially managed with oral antihistamines and oral steroids. However, over the years her symptoms increased in frequency, intensity, and duration. Montelukast 10 mg daily started which did not show any improvement. In 2017 Mepolizumab 100 mg every 4 weeks started. The patient noted improvement after a few months, and she was tolerating her injections well without side effects and had no further flares of her condition. Discussion: We present a case of eosinophilic cystitis which was refractory to multiple treatments and responded well to mepolizumab. There are no definite guidelines for the management of EC and there is no curative treatment for this disease. Mepolizumab is an anti-IL-5 monoclonal antibody and the use of mepolizumab in the management of EC that is refractory to treatment have been reported in a few cases. The use of mepolizumab has been described in different diseases associated with eosinophilic inflammation such as severe eosinophilic asthma, eosinophilic esophagitis, eosinophilic chronic obstructive pulmonary disease, and severe nasal polyposis. Conclusion: Mepolizumab can be considered a treatment option in EC cases refractory to the standard treatment. At this time, larger studies are needed to evaluate the efficacy and safety of mepolizumab in EC." @default.
- W4324144811 created "2023-03-15" @default.
- W4324144811 creator A5013862674 @default.
- W4324144811 creator A5047672370 @default.
- W4324144811 date "2023-03-01" @default.
- W4324144811 modified "2023-09-27" @default.
- W4324144811 title "A Case of Eosinophilic Cystitis treated with Mepolizumab" @default.
- W4324144811 cites W1968876836 @default.
- W4324144811 cites W1975262759 @default.
- W4324144811 cites W2033559734 @default.
- W4324144811 cites W2047001363 @default.
- W4324144811 cites W2095754126 @default.
- W4324144811 cites W2136465680 @default.
- W4324144811 cites W2137089454 @default.
- W4324144811 cites W2138355864 @default.
- W4324144811 cites W2268352107 @default.
- W4324144811 cites W2412650235 @default.
- W4324144811 cites W2756335179 @default.
- W4324144811 cites W3007422627 @default.
- W4324144811 cites W3128418720 @default.
- W4324144811 doi "https://doi.org/10.2174/04666230313100005" @default.
- W4324144811 hasPublicationYear "2023" @default.
- W4324144811 type Work @default.
- W4324144811 citedByCount "0" @default.
- W4324144811 crossrefType "journal-article" @default.
- W4324144811 hasAuthorship W4324144811A5013862674 @default.
- W4324144811 hasAuthorship W4324144811A5047672370 @default.
- W4324144811 hasBestOaLocation W43241448111 @default.
- W4324144811 hasConcept C126322002 @default.
- W4324144811 hasConcept C141071460 @default.
- W4324144811 hasConcept C16005928 @default.
- W4324144811 hasConcept C2776042228 @default.
- W4324144811 hasConcept C2777037409 @default.
- W4324144811 hasConcept C2777129736 @default.
- W4324144811 hasConcept C2777832160 @default.
- W4324144811 hasConcept C2778769751 @default.
- W4324144811 hasConcept C2779134260 @default.
- W4324144811 hasConcept C2781065132 @default.
- W4324144811 hasConcept C71924100 @default.
- W4324144811 hasConcept C77411442 @default.
- W4324144811 hasConcept C90924648 @default.
- W4324144811 hasConceptScore W4324144811C126322002 @default.
- W4324144811 hasConceptScore W4324144811C141071460 @default.
- W4324144811 hasConceptScore W4324144811C16005928 @default.
- W4324144811 hasConceptScore W4324144811C2776042228 @default.
- W4324144811 hasConceptScore W4324144811C2777037409 @default.
- W4324144811 hasConceptScore W4324144811C2777129736 @default.
- W4324144811 hasConceptScore W4324144811C2777832160 @default.
- W4324144811 hasConceptScore W4324144811C2778769751 @default.
- W4324144811 hasConceptScore W4324144811C2779134260 @default.
- W4324144811 hasConceptScore W4324144811C2781065132 @default.
- W4324144811 hasConceptScore W4324144811C71924100 @default.
- W4324144811 hasConceptScore W4324144811C77411442 @default.
- W4324144811 hasConceptScore W4324144811C90924648 @default.
- W4324144811 hasIssue "1" @default.
- W4324144811 hasLocation W43241448111 @default.
- W4324144811 hasOpenAccess W4324144811 @default.
- W4324144811 hasPrimaryLocation W43241448111 @default.
- W4324144811 hasRelatedWork W1968973890 @default.
- W4324144811 hasRelatedWork W1989690584 @default.
- W4324144811 hasRelatedWork W2033559734 @default.
- W4324144811 hasRelatedWork W2088676865 @default.
- W4324144811 hasRelatedWork W2152194280 @default.
- W4324144811 hasRelatedWork W2341239715 @default.
- W4324144811 hasRelatedWork W2916150391 @default.
- W4324144811 hasRelatedWork W2922809015 @default.
- W4324144811 hasRelatedWork W2977541676 @default.
- W4324144811 hasRelatedWork W3192688925 @default.
- W4324144811 hasVolume "4" @default.
- W4324144811 isParatext "false" @default.
- W4324144811 isRetracted "false" @default.
- W4324144811 workType "article" @default.